In line with previous studies [9, 12], treatment with p38i reduced tumor growth compared to vehicle-control, whereas depletion of CD8+ T cells alleviated this anti-tumor effect of p38i (Fig. 1c, Suppl. This evidence concerns the gene CD8A and neoplasm.